Mixed
Intensive, multicomponent lifestyle intervention (diet, exercise, behavioral counseling) remains foundational and synergistic with anti-obesity medications (GLP-1 RAs), improving outcomes and mitigating side effects, whereas relying on medication alone without lifestyle support may lead to suboptimal results and higher discontinuation.
Do not skip lifestyle changes just because you are taking weight-loss medication. Combine your medication with a structured plan involving diet, exercise, and behavioral counseling. This approach maximizes your weight loss, helps you keep the weight off, and can reduce medication side effects like nausea. Aim for 200-300 minutes of moderate exercise per week and attend intensive counseling sessions (at least 12 in the first year).
Best practice guidelines recommend lifestyle intervention in conjunction with the treatment of obesity. Additionally, discontinuation rates for GLP-1 RAs can be very high for a variety of reasons... Both semaglutide and tirzepatide were FDA approved to be provided in conjunction with a reduced calorie diet and exercise... There is some evidence for improvement in outcome for GLP-1 RAs when combined with lifestyle change... This suggests that additional benefit may be derived from pairing GLP-1 RA medication with intensive lifestyle intervention.
Why this rating
Based on a narrative review citing multiple RCTs (MODEL-IBT, SURMOUNT-3) and FDA approvals.
Source
Lifestyle Medicine for Obesity in the Era of Highly Effective Anti-Obesity Treatment
Deepa Sannidhi et al. · Nutrients · 2025
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →